לברסט

Country: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

LETROZOLE 2.5 MG

Boleh didapati daripada:

RAFA LABORATORIES LTD

Kod ATC:

L02BG04

Borang farmaseutikal:

FILM COATED TABLETS

Laluan pentadbiran:

PER OS

Dikeluarkan oleh:

SIEGFRIED GENERICS ( MALTA) LTD

Kumpulan terapeutik:

LETROZOLE

Tanda-tanda terapeutik:

Letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Tarikh kebenaran:

2012-04-01